Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases

E Samy, S Wax, B Huard, H Hess… - International reviews of …, 2017 - Taylor & Francis
The B cell-stimulating molecules, BAFF (B cell activating factor) and APRIL (a proliferation-
inducing ligand), are critical factors in the maintenance of the B cell pool and humoral …

Effect of TACI signaling on humoral immunity and autoimmune diseases

Y Zhang, J Li, YM Zhang, XM Zhang… - Journal of immunology …, 2015 - Wiley Online Library
Transmembrane activator and calcium‐modulating cyclophilin ligand interactor (TACI) is
one of the receptors of B cell activating factor of the tumor necrosis factor family (BAFF) and …

Pleiotropic effects of BAFF on the senescence-associated secretome and growth arrest

M Rossi, C Anerillas, ML Idda, R Munk, CH Shin… - Elife, 2023 - elifesciences.org
Senescent cells release a variety of cytokines, proteases, and growth factors collectively
known as the senescence-associated secretory phenotype (SASP). Sustained SASP …

[HTML][HTML] B cell dysregulation in common variable immunodeficiency interstitial lung disease

EM Matson, ML Abyazi, KA Bell, KM Hayes… - Frontiers in …, 2021 - frontiersin.org
Common variable immunodeficiency (CVID) is the most frequently diagnosed primary
antibody deficiency. About half of CVID patients develop chronic non-infectious …

Shedding of BAFF/APRIL receptors controls B cells

E Meinl, FS Thaler, SF Lichtenthaler - Trends in immunology, 2018 - cell.com
Proteolytic shedding of the receptors BCMA, TACI, and BAFFR reduces their cell-surface
expression and ligand-mediated survival of B cell subsets. This shedding is executed by …

Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus

W Stohl - Expert opinion on therapeutic targets, 2014 - Taylor & Francis
Introduction: The B-cell activating factor (BAFF) axis comprises two ligands (BAFF and
APRIL) and three receptors (BCMA, TACI, BR3). BAFF is a vital B-cell survival factor and …

[HTML][HTML] Function, occurrence and inhibition of different forms of BAFF

M Eslami, P Schneider - Current Opinion in Immunology, 2021 - Elsevier
B cell activating factor (BAFF or BLyS), an important cytokine for B cell survival and humoral
immune responses, is targeted in the clinic for the treatment of systemic lupus …

[HTML][HTML] A loop region of BAFF controls B cell survival and regulates recognition by different inhibitors

M Vigolo, MG Chambers, L Willen, D Chevalley… - Nature …, 2018 - nature.com
The B cell survival factor (TNFSF13B/BAFF) is often elevated in autoimmune diseases and is
targeted in the clinic for the treatment of systemic lupus erythematosus. BAFF contains a …

[HTML][HTML] Inhibition of membrane-bound BAFF by the anti-BAFF antibody belimumab

C Kowalczyk-Quintas, D Chevalley, L Willen… - Frontiers in …, 2018 - frontiersin.org
B cell activating factor of the TNF family (BAFF, also known as BLyS), a cytokine that
regulates homeostasis of peripheral B cells, is elevated in the circulation of patients with …

TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection

WR Allman, R Dey, L Liu, S Siddiqui… - Proceedings of the …, 2015 - National Acad Sciences
The TNF family member, transmembrane activator and calcium-modulator and cyclophilin
ligand interactor (TACI), is a key molecule for plasma cell maintenance and is required in …